
A GLP-1 weight loss injection that curbs appetite and improves blood sugar control as part of a medically supervised program. Structured dosing, provider monitoring, and real accountability.
Patients with high BMI, difficulty controlling appetite, type 2 diabetes or prediabetes, and those who want a clinically proven GLP-1 option with established long-term safety data.
Liraglutide mimics the gut hormone GLP-1, binding to receptors in the pancreas, brain, and GI tract. It increases insulin secretion when blood sugar is elevated, slows gastric emptying so you feel full longer, and activates satiety centers in the hypothalamus. Daily subcutaneous injections are titrated to your tolerance and response.
We monitor every Liraglutide patient with regular check-ins, dose adjustments, and lab work as needed. This isn't a prescription-and-go program. You get a provider who tracks your progress and adjusts your plan when it matters. Lincoln Park clinic or Illinois telehealth.

We're here to answer your questions and provide the best services for your needs. Schedule a consultation to learn how to reach your aesthetic goals.
Better Med Spa’s Liraglutide program uses a daily GLP‑1 receptor agonist injection (Saxenda‑equivalent dosing) to slow gastric emptying, enhance satiety signals, and improve insulin response, helping you eat less, feel fuller, and lose clinically meaningful weight over time. The program layers medication with nutrition, movement, and mindset support, plus safety monitoring for GI, gallbladder, thyroid, and mood‑related risks.
Liraglutide is a GLP‑1 receptor agonist that mimics the gut hormone GLP‑1, binding to GLP‑1 receptors in the pancreas, brain, and GI tract. This increases glucose‑dependent insulin secretion, decreases glucagon, slows gastric emptying, and activates satiety centers in the hypothalamus, leading to reduced hunger, smaller portions, and improved post‑meal glucose control. Clinical trials (e.g., SCALE) show that high‑dose liraglutide can produce significant weight loss and improvements in prediabetes, lipids, and blood pressure when combined with a reduced‑calorie diet and increased activity.
Liraglutide is designed to target:
Liraglutide is believed to help with: